molprofiles.co.uk Report : Visit Site

Technical data of the molprofiles.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host molprofiles.co.uk. Currently, hosted in United Kingdom and its service provider is CAN Colocation Customers .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.15 (Red Hat) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all article/whitepaper brochure case study ebook offering info poster presentation webinars news & events about us careers contact us visit another site global our regional sites china korea japan south america portuguese spanish subscribe careers locations investors fusion global visit another site global our regional sites china korea japan south america portuguese spanish development delivery supply offerings view all biologics oral technologies inhalation development solutions sterile technologies clinical supply services consumer thinking view all article/whitepaper brochure case study ebook offering info poster presentation webinars news & events about us careers contact us home catalent acquires juniper pharmaceuticals + share print catalent acquires juniper pharmaceuticals acquisition strengthens catalent's global early-phase development capabilities nottingham, u.k.-based dose form development and clinical manufacturing specialist, juniper has been added as a european early development center of excellence to catalent’s global network. when combined with catalent’s existing centers of excellence for early drug development in the u.s. and europe, the acquisition of juniper expands and strengthens catalent’s offerings and complements its integrated global clinical and commercial supply network. read full press release here. download more details here. learn more about career opportunities in nottingham juniper's commitment to science-based, solutions oriented development and to quality and operational excellence fits well with catalent’s data-driven, consultative approach to early development. catalent’s pharmaceutical customers will now be able to take advantage of accelerated and comprehensive clinical development and manufacturing capabilities at a location of their choice with seamless scale up to later clinical stages and commercial launch capabilities within catalent's global network. learn more about catalent’s early-phase development capabilities, including: accelerated bioavailability solutions with optiform® solution suite superior drug delivery technologies integrated manufacturing and supply services scale up to launch and commercial supply about juniper pharmaceuticals a uk-based development partner focused on formulation and analytical development and early-phase clinical manufacturing of complex, small-molecule compounds, juniper offers science-driven innovation and a portfolio of solutions to help customers reduce risk and accelerate their key drug development programs from discovery to the clinic. offerings include: analytical characterization and preformulation testing formulation development with specific expertise in development of enabled formulations for bioavailability enhancement, including spray drying , hot melt extrusion, micronization and nano-milling clinical manufacturing of capsules and tablets, including highly potent compounds and controlled substances handling contact us to find out about how we can help solve your development challenges. *the services described on this page are supplied in the u.k. by a wholly owned subsidiary of catalent named juniper pharma services limited, 8 orchard place, nottingham business park, nottingham ng8 6px, u.k. related topics early stage oral development optiform® solution suite catalent spray drying technology bioavailability solutions catalent micron technologies related thinking technical guide for solid dispersion development delivering the right drug candidate in the early phase best practices for identifying development candidates contact us contact us resource library subscribe investors careers contact us site map follow us. share us. -- copyright 2019, catalent, inc - all right reserved privacy terms modern slavery statement | privacy shield statement

URL analysis for molprofiles.co.uk

http://www.catalent.com/index.php
https://www.catalent.com/index.php/news-events/news/catalent-completes-tender-offer-for-all-outstanding-shares-of-juniper-pharmaceuticals-inc
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/offerings?type=clinicalsupplyservices
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals//javascript:
void(0);
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/supply
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/thinking?type=brochure
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/offerings/a-z-offerings/catalent-micron-technologies
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/news-events
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/development
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/thinking/science/best-practices-for-identifying-development-candidates-and-formulation-strategy-in-the-early-phase
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/offerings?type=oraltechnologies
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/thinking?type=webinars
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/offerings?type=biologics
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/development/catalent-spray-drying-technology
https://www.catalent.com/index.php/campaign/Catalent-Acquires-Juniper-Pharmaceuticals///index.php/offerings?type=steriletechnologies

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "molprofiles.co.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 457 seconds

WHOIS lookup made at 01:34:50 01-Sep-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS molprofiles.co.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME molprofiles.co.uk

NSERVER

  NS1.MYTHIC-BEASTS.COM 45.33.127.156

  NS2.MYTHIC-BEASTS.COM 93.93.128.67

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .